INDIVIOR
PLC (THE 'COMPANY') - SHARE REPURCHASE PROGRAM WEEKLY REPORT -
CORRECTION
The following amendment has been made to the
'Transaction in Own Shares' announcement released on January 14,
2025 at 07:00 under RNS number: 1400T.
In relation to the shares purchased by the
Company, the purchase start date was incorrectly stated.
The purchase start date has changed from January
6, 2024 to January 6, 2025.
All other details remain unchanged.
The full amended text is shown
below.
January 14, 2025
INDIVIOR PLC
("Indivior") announces that
it purchased for cancellation a total of 194,876 of
its ordinary shares of $0.50 each through Morgan Stanley & Co.
International Plc in the period from January 6, 2025, up to and
including January 10, 2025, in connection with its $100m Share
Repurchase Program. Aggregated information on the purchase of these
shares can be found in the table below.
Following the purchase and cancellation of the
above shares (including those purchased but not yet settled),
Indivior has 124,633,727 ordinary shares of $0.50 each with voting
rights in issue. There are no shares held in treasury.
The above figure (124,633,727) may be used by
shareholders (and others with notification obligations) as the
denominator for the calculation by which they will determine if
they are required to notify their interest in, or a change to their
interest in, Indivior under the FCA's Disclosure Guidance and
Transparency Rules.
All repurchases by Indivior are "On Exchange"
transactions (as such term is defined in the rules of the London
Stock Exchange) and "on market" for the purposes of the Companies
Act 2006.
Aggregated
information
Trading
Date
|
Trading
Venue
|
Aggregated daily
volume (number of shares)
|
Daily weighted
average purchase price of the shares (p)
|
06/01/2025
|
LSE
|
16,616
|
1,000.29
|
06/01/2025
|
BATE
|
3,315
|
998.31
|
06/01/2025
|
CHIX
|
14,842
|
1,002.78
|
06/01/2025
|
AQUIS
|
3,008
|
986.27
|
07/01/2025
|
LSE
|
15,525
|
960.18
|
07/01/2025
|
BATE
|
4,814
|
962.81
|
07/01/2025
|
CHIX
|
16,484
|
959.91
|
07/01/2025
|
AQUIS
|
2,262
|
962.54
|
08/01/2025
|
LSE
|
14,400
|
973.59
|
08/01/2025
|
BATE
|
8,461
|
972.32
|
08/01/2025
|
CHIX
|
13,838
|
970.18
|
08/01/2025
|
AQUIS
|
1,886
|
968.28
|
09/01/2025
|
LSE
|
12,427
|
979.10
|
09/01/2025
|
BATE
|
6,265
|
980.81
|
09/01/2025
|
CHIX
|
19,824
|
980.46
|
09/01/2025
|
AQUIS
|
895
|
979.90
|
10/01/2025
|
LSE
|
17,670
|
973.98
|
10/01/2025
|
BATE
|
6,914
|
973.89
|
10/01/2025
|
CHIX
|
13,796
|
974.69
|
10/01/2025
|
AQUIS
|
1,634
|
974.90
|
Transaction
details
In accordance with Article 5(1)(b) of the
assimilated Market Abuse Regulation (EU) No 596/2014, as it forms
part of Retained EU Law as defined in the European Union
(Withdrawal) Act 2018 and Commission Delegated Regulation (EU)
2016/1052, a full breakdown of the individual purchases of ordinary
shares made by Morgan Stanley & Co. International Plc on behalf
of Indivior during the above period as part of the Share Repurchase
Program can be found at
www.indivior.com/en/investors/shareholder-information/share-repurchase-program.
Indivior PLC's Legal Entity Identifier code is
213800V3NCQTY7IED471.
Contact:
Jason Thompson
Vice President, Investor Relations
1-804-402-7123